Smoking rates are down nationally, but so are discussions among physicians and smokers about lung cancer screening, University of Florida researchers have found. However, the study also found these patient-physician conversations did not affect current smokers’ intent or attempts to quit. READ MORE
At a time when overdose deaths from prescription and non-prescription opioids have reached epidemic proportions, researchers at the University of Florida College of Medicine’s Department of Otolaryngology — part of UF Health, the Southeast’s most comprehensive academic health center — have taken a closer look at chronic opioid use in patients with oropharyngeal squamous cell carcinoma. The retrospective analysis, which will be published in Laryngoscope in early 2019, found that an alarming number of patients were chronic opioid users three months after treatment. READ MORE
Cannabidiol, or CBD, has become a household name. On many social media sites, people suggest “but have you tried CBD oil?” on posts pertaining to any health-related issue.
CBD, a minor constituent of marijuana, is widely touted as nature’s miracle by CBD enthusiasts. It does not get people high, unlike marijuana’s main constituent, delta-9-tetrahydrocannabinol (THC). However, given the recent surge in its popularity, you’d think the molecule is magic.
We are behavioral pharmacology scientists, and we study how drugs act on the body. Specifically, we have an interest in developing new drugs for the treatment of pain that possess lessened drug abuse potential, and therapeutic interventions for drug abuse. Although there is scientific interest in the use of CBD for both pain and drug addiction, as well as many other medical indications, there is a lot that we still do not know about CBD. READ MORE
In the 1980s, pharmaceutical companies tried to build opioid painkillers that wouldn’t lead to addiction by taking advantage of an interesting phenomenon that happens when targeting the kappa opioid receptor in the brain. Compounds that activate this receptor cause both pleasant side-effects, like euphoria, and less pleasant ones, like depression. The hope in targeting this receptor was that the less pleasant side effects would quell the pleasant ones that often led to misuse. READ MORE